Krecko Laura K, Hoyos Gomez Tatiana, Scarborough John E, Jung Hee Soo
Department of Surgery, University of Wisconsin Hospital and Clinics, Madison, WI.
Department of Surgery, University of Wisconsin Hospital and Clinics, Madison, WI.
J Am Coll Surg. 2021 Apr;232(4):344-349. doi: 10.1016/j.jamcollsurg.2020.11.034. Epub 2021 Jan 20.
Gallbladder perforation is a known morbid sequela of acute cholecystitis, yet evidence for its optimal management remains conflicting. This study compares outcomes in patients with perforated cholecystitis who underwent cholecystectomy at the time of index hospital admission with those in patients who underwent interval cholecystectomy.
A retrospective analysis was conducted of 654 patients from the American College of Surgeons NSQIP database who underwent cholecystectomy for perforated cholecystitis (2006-2018). Primary outcomes were 30-day postoperative major and minor morbidity, 30-day mortality, and need for prolonged hospitalization. Patient and procedure characteristics and outcomes were compared using Mann-Whitney rank sum test for continuous variables and Pearson chi-square tests for categorical variables. A subset analysis was conducted of patients matched on propensity for undergoing interval cholecystectomy.
The 30-day postoperative mortality rate of matched cohort patients undergoing index cholecystectomy was 7% vs 0% of patients undergoing interval cholecystectomy (p = 0.01). The 30-day minor morbidity rates were 2% for index and 8% for interval patients (p = 0.06), and the major morbidity rates were 33% for index and 14% for interval patients (p = 0.003). Of the index patients, 27% required prolonged hospitalization compared with 6% of interval patients (p < 0.001). Results showed similar trends in the unmatched analysis.
Patients who underwent index cholecystectomy had significantly longer postoperative hospitalizations and higher 30-day postoperative major morbidity and mortality. There were no differences in 30-day minor morbidity. Selected patients with perforated cholecystitis can benefit from operative management on an interval, rather than urgent, basis.
胆囊穿孔是急性胆囊炎已知的一种严重并发症,然而关于其最佳治疗方法的证据仍存在争议。本研究比较了在首次住院时接受胆囊切除术的穿孔性胆囊炎患者与接受择期胆囊切除术的患者的治疗结果。
对美国外科医师学会国家外科质量改进计划(NSQIP)数据库中654例因穿孔性胆囊炎接受胆囊切除术的患者(2006 - 2018年)进行回顾性分析。主要结局指标为术后30天的严重及轻微并发症、30天死亡率以及延长住院时间的需求。连续变量采用Mann-Whitney秩和检验,分类变量采用Pearson卡方检验比较患者和手术特征及结局。对倾向于接受择期胆囊切除术的患者进行亚组分析。
接受首次胆囊切除术的匹配队列患者的术后30天死亡率为7%,而接受择期胆囊切除术的患者为0%(p = 0.01)。首次手术患者的30天轻微并发症发生率为2%,择期手术患者为8%(p = 0.06),严重并发症发生率分别为33%和14%(p = 0.003)。首次手术患者中,27%需要延长住院时间,而择期手术患者为6%(p < 0.001)。在未匹配分析中结果显示出类似趋势。
接受首次胆囊切除术的患者术后住院时间显著更长,术后30天严重并发症及死亡率更高。30天轻微并发症方面无差异。部分穿孔性胆囊炎患者可从择期而非急诊手术治疗中获益。